| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,537 |
6,724 |
$931K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19,999 |
6,030 |
$406K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
25,457 |
7,140 |
$401K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
11,751 |
3,413 |
$355K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,004 |
3,255 |
$178K |
| 99233 |
Prolong inpt eval add15 m |
4,806 |
1,079 |
$144K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,273 |
4,461 |
$124K |
| 96367 |
|
9,200 |
3,358 |
$120K |
| J3490 |
Unclassified drugs |
7,990 |
2,219 |
$89K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,778 |
4,641 |
$80K |
| 36415 |
Collection of venous blood by venipuncture |
17,911 |
6,974 |
$62K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,019 |
598 |
$49K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,594 |
1,622 |
$39K |
| 99223 |
Prolong inpt eval add15 m |
747 |
709 |
$39K |
| 99000 |
|
12,831 |
4,798 |
$32K |
| J1756 |
Injection, iron sucrose, 1 mg |
822 |
218 |
$31K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
8,468 |
3,095 |
$30K |
| J7050 |
Infusion, normal saline solution, 250 cc |
27,585 |
7,791 |
$28K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
23,389 |
6,890 |
$19K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,460 |
549 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
718 |
459 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
178 |
90 |
$9K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
295 |
139 |
$7K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
83 |
40 |
$6K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
28 |
12 |
$5K |
| S0028 |
Injection, famotidine, 20 mg |
7,771 |
1,891 |
$3K |
| 99195 |
|
257 |
123 |
$2K |
| 85027 |
|
223 |
158 |
$226.26 |
| 96415 |
|
18 |
12 |
$214.89 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
19 |
12 |
$208.70 |
| J1750 |
Injection, iron dextran, 50 mg |
26 |
12 |
$195.14 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
273 |
225 |
$188.79 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
19 |
19 |
$12.37 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
17 |
17 |
$0.00 |
| 1126F |
|
20 |
20 |
$0.00 |
| 1036F |
|
21 |
21 |
$0.00 |